Discover how Fibroblast Growth Factor 23 (FGF23) acts as a critical biomarker in kidney disease, correlating with mineral imbalances and cardiovascular risks.
Discover how the COL4A4-G394S variant disrupts collagen IV trimerization, leading to mild Alport syndrome and kidney disease progression.